Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Transurethral alprostadil/prazosin for erectile dysfunction

April 15, 1997

Fluoxetine for the management of premature ejaculation

April 15, 1997

Lilly reports compounds for postmenopausal syndrome

April 15, 1997

Pharmacia & Upjohn introduces new GH delivery device

April 14, 1997

Orally active GH secretagogues reported by Lilly

April 14, 1997

Lilly granted rights to gene/protein involved in islet neogenesis

April 11, 1997

Canadian approval for Depo-Provera

April 10, 1997

Amgen obtains additional EPO patent protection

April 10, 1997

Roussel Uclaf transfers all rights and responsibilities related to mifepristone to Dr. Sakiz

April 10, 1997

GelTex issued U.S. patent for cholesterol-reducing polymers

April 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...